Rossari Financial Statements From 2010 to 2024

Stocks India . 
Stock . Rossari Biotech Limited
ROSSARI Stock   784.95  3.70  0.47%   
Rossari Biotech financial statements provide useful quarterly and yearly information to potential Rossari Biotech Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Rossari Biotech financial statements helps investors assess Rossari Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rossari Biotech's valuation are summarized below:
Gross Profit
3.7 B
Profit Margin
0.0721
Market Capitalization
43.9 B
Enterprise Value Revenue
2.3046
Revenue
19.2 B
We have found eighty-six available trending fundamental ratios for Rossari Biotech, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Rossari Biotech recent fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.

Rossari Biotech Total Revenue

10.05 Billion

Check Rossari Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rossari Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 320 M, Interest Expense of 203.4 M or Total Revenue of 10 B, as well as many indicators such as . Rossari financial statements analysis is a perfect complement when working with Rossari Biotech Valuation or Volatility modules.
  
This module can also supplement various Rossari Biotech Technical models . Check out the analysis of Rossari Biotech Correlation against competitors.

Rossari Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.9 B15.7 B4.9 B
Slightly volatile
Short and Long Term Debt Total1.2 B1.2 B403.8 M
Slightly volatile
Other Current Liabilities1.4 B1.3 B326.7 M
Slightly volatile
Total Current Liabilities2.2 B4.2 B1.5 B
Slightly volatile
Total Stockholder Equity11 B10.5 B3.5 B
Slightly volatile
Other Liabilities1.9 B1.8 B472.2 M
Slightly volatile
Net Tangible Assets6.6 B6.3 B2.5 B
Slightly volatile
Property Plant And Equipment Net2.1 B4.3 B1.4 B
Slightly volatile
Retained Earnings5.9 B5.6 B1.9 B
Slightly volatile
Accounts Payable1.4 B2.2 B891.9 M
Slightly volatile
Cash254.9 M251.7 M149.1 M
Slightly volatile
Non Current Assets Total7.7 B7.3 B2.4 B
Slightly volatile
Non Currrent Assets Other122.5 M104.4 M73.9 M
Slightly volatile
Other Assets114.4 M165.6 M77.3 M
Slightly volatile
Cash And Short Term Investments732.6 M667.9 M412.9 M
Slightly volatile
Common Stock Shares Outstanding53.1 M55.3 M38.1 M
Slightly volatile
Short Term Investments477.7 M416.1 M263.8 M
Slightly volatile
Liabilities And Stockholders Equity7.9 B15.7 B4.9 B
Slightly volatile
Non Current Liabilities Total568.9 M996.9 M331.1 M
Slightly volatile
Inventory3 B2.8 B922.6 M
Slightly volatile
Other Current Assets5.2 B4.9 B1 B
Slightly volatile
Total Liabilities2.8 B5.2 B1.8 B
Slightly volatile
Total Current Assets4.4 B8.4 B2.8 B
Slightly volatile
Intangible Assets1.5 B1.4 B428.1 M
Slightly volatile
Common Stock91.9 M110.5 M68.3 M
Slightly volatile
Property Plant Equipment4.2 B4 B1.5 B
Slightly volatile
Net Invested Capital6.2 B11.5 B3.6 B
Slightly volatile
Net Working Capital2.5 B4.2 B1.4 B
Slightly volatile
Capital Stock106.4 M110.5 M69.2 M
Slightly volatile
Good Will731.6 M1.4 B298.1 M
Slightly volatile
Property Plant And Equipment Gross3.2 B3.6 B2 B
Slightly volatile
Accumulated Other Comprehensive Income28.4 M35.4 M13.4 M
Slightly volatile
Non Current Liabilities Other63.2 M66.5 M693.8 M
Slightly volatile
Capital Lease Obligations103.7 M116.7 M127.1 M
Slightly volatile

Rossari Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization320 M603.9 M193.9 M
Slightly volatile
Interest Expense203.4 M193.7 M66.2 M
Slightly volatile
Total Revenue10 B18.3 B6.5 B
Slightly volatile
Gross Profit2.6 B3.2 B1.6 B
Slightly volatile
Other Operating Expenses9 B16.4 B5.8 B
Slightly volatile
Operating Income1.1 B1.8 B666.5 M
Slightly volatile
EBIT1.1 B2 B703 M
Slightly volatile
Research Development63 M70.2 M53.6 M
Slightly volatile
EBITDA1.4 B2.6 B896.9 M
Slightly volatile
Cost Of Revenue15.9 B15.1 B5.4 B
Slightly volatile
Total Operating Expenses5.5 B5.2 B1.4 B
Slightly volatile
Income Before Tax1.1 B1.8 B660.6 M
Slightly volatile
Net Income Applicable To Common Shares602.3 M1.1 B456.3 M
Slightly volatile
Net Income778.9 M1.3 B486.7 M
Slightly volatile
Income Tax Expense283.3 M469.3 M174 M
Slightly volatile
Tax Provision316.8 M469.3 M211.9 M
Slightly volatile
Interest Income24.9 M29 M15 M
Slightly volatile
Selling General Administrative107.3 M169.7 M67.8 M
Slightly volatile
Selling And Marketing Expenses467.4 M643.6 M273.3 M
Slightly volatile
Net Income From Continuing Ops867.5 M1.3 B544.4 M
Slightly volatile
Reconciled Depreciation359.1 M603.9 M200.4 M
Slightly volatile

Rossari Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow726.6 M692 M164.2 M
Slightly volatile
Depreciation320.2 M603.9 M193.9 M
Slightly volatile
Capital Expenditures1.4 B1.3 B373.1 M
Slightly volatile
Total Cash From Operating Activities589.9 M432.6 M344.1 M
Slightly volatile
Net Income991.1 M1.3 B603.8 M
Slightly volatile
End Period Cash Flow254.9 M251.7 M149.1 M
Slightly volatile
Stock Based Compensation12.7 M9.2 M7.5 M
Slightly volatile

Rossari Fundamental Market Drivers

Cash And Short Term Investments667.9 M

About Rossari Biotech Financial Statements

Investors use fundamental indicators, such as Rossari Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rossari Biotech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue125.1 M118.8 M
Total Revenue18.3 B10 B
Cost Of Revenue15.1 B15.9 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Rossari Stock

Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY